NCT05954715

Brief Summary

Regular physical activity improves physical fitness, fatigue, quality of life, gait and reduces progression of the disability in persons with SCI. However, persons with SCI are less physically active than the general population. Approximately 50% of people with SCI experience fatigue which impacts their daily activities. Ischaemic preconditioning (IPC) is exposure of the body to brief periods of circulatory occlusion and reperfusion to protect organs against ischaemic injury. Recent studies have shown that IPC also improves exercise performance in healthy participants. The aim of this study is to determine whether it is feasible to use IPC to improve upper-body exercise performance in people with SCI. Setting: Potential candidates will be identified from the Outpatient clinic at the Princess Royal Spinal Injuries Hospital (PRSCIC), Northern General Hospital, Sheffield. Design: Acute single blind randomised controlled trial. Forty patients with SCI above 18 years and with preserved triceps function to conduct triceps strength testing will be randomised to receive either an IPC or sham intervention. Interventions: IPC will be administered to the upper limb using cuff inflation pressures of 200 mmHg or 60mm Hg above the systolic BP (whichever is higher). Four cycles of cuff inflation each lasting 5 min in duration followed by 5-min period of cuff deflation will be applied. The Sham intervention will be administered with a BP cuff over the upper arm being inflated at a pressure 30mmg Hg below the diastolic blood pressure. The sham cycles will comprise of four cycles of cuff inflation each lasting 5 min in duration followed by 5-min period of cuff deflation. Researchers will assess the feasibility of IPC as well as its efficacy to improve triceps maximal voluntary contraction and endurance compared with Sham.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 30, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

July 20, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

August 2, 2023

Status Verified

July 1, 2023

Enrollment Period

1.2 years

First QC Date

June 30, 2023

Last Update Submit

July 31, 2023

Conditions

Keywords

Exercise capacityTolerabilityIschaemic preconditioningMaximal voluntary contractionTime to task failureFatigue

Outcome Measures

Primary Outcomes (1)

  • Intervention feasibility

    The intervention will be considered feasible if all of the below criteria are met: * 80% of the target sample is recruited within the first 9 months after the start of recruitment. * Of those who participate, 80% tolerate the ischemic preconditioning intervention, defined as ratings \<7 using the numerical Pain Rating Scale that ranges from 0 to 10. Here 0 is considered no pain; 1 to 3 is mild pain; 4 to 6 is moderate pain and 7 to 10 is severe pain. * A full data set is obtained in 80% of the participants who start the intervention.

    Recruitment figures and tolerability will be collected throughout the 1 year study period.

Secondary Outcomes (2)

  • Maximal voluntary muscle contraction

    Maximal voluntary muscle contraction will be collected throughout the 1 year study period.

  • Time to task failure during rhythmic muscle contraction

    Time to task failure during rhythmic muscle contraction will be collected throughout the 1 year study period.

Other Outcomes (3)

  • Blood lactate concentration

    Blood lactate concentration will be collected throughout the 1 year study period.

  • Ratings of perceived exertion

    Ratings of perceived extertion will be collected throughout the 1 year study period.

  • Electromyographic activity (EMG) at the triceps head

    Electromyographic activity (EMG) at the triceps head will be collected throughout the 1 year study period.

Study Arms (2)

IPC (Ischaemic Preconditioning)

EXPERIMENTAL

IPC will be administered to the upper limb using cuff inflation pressures of 200 mmHg or 60mm Hg above the systolic BP (whichever is higher). Four cycles of cuff inflation each lasting 5 min in duration followed by a 5-min period of cuff deflation will be applied.

Other: Ischaemic Preconditioning

Sham

SHAM COMPARATOR

The Sham intervention will be administered with a BP cuff over the upper arm being inflated at a pressure 30mmg Hg below the diastolic blood pressure. The sham cycles will comprise of four cycles of cuff inflation each lasting 5 min in duration followed by a 5-min period of cuff deflation.

Other: Sham

Interventions

Four cycles of cuff inflation each lasting 5 min in duration followed by a 5-min period of cuff deflation will be applied.

IPC (Ischaemic Preconditioning)
ShamOTHER

Four cycles of cuff inflation each lasting 5 min in duration followed by a 5-min period of cuff deflation will be applied.

Sham

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age of 18 or older
  • Chronic spinal cord injury (\>1 year post injury)

You may not qualify if:

  • ASIA Impairment scale E
  • Other co-morbidities- Traumatic brain injury, Brachial plexus injury, upper limb fractures, progressive neurological conditions (e.g., multiple sclerosis)
  • Patients known to have autonomic dysreflexia (AD) and having had an episode of AD in the last two weeks
  • Impaired triceps function (medical research council (MRC) power motor score of 3 out of 5, or lower)
  • Resting systolic BP of 170 mmHg or more
  • Inability to communicate in English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Spinal Cord InjuriesFatigue

Interventions

Ischemic Preconditioningsalicylhydroxamic acid

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

TherapeuticsInvestigative Techniques

Study Officials

  • Christof Leicht, PhD

    Loughborough University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sven Hoekstra, PhD

CONTACT

Rohit Bhide, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Both Sham and IPC consist of 5 min bouts of cuff inflation, using an identical cuff. While the applied pressure will differ between conditions, this will not be communicated with the study participants prior to the experiment.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Acute single blind randomised controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer in Physiology and Rehabilitation Sciences

Study Record Dates

First Submitted

June 30, 2023

First Posted

July 20, 2023

Study Start

November 1, 2023

Primary Completion

December 31, 2024

Study Completion

July 1, 2025

Last Updated

August 2, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share